Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count

Journal of Developmental and Behavioral Pediatrics

Volumn 29, Issue 5, 2008, Pages 377-384

  Farley, John J ^a   Montepiedra, Grace ^b   Storm, Deborah ^c   Sirois, Patricia A ^d   Malee, Kathleen ^e   Garvie, Patricia ^f   Kammerer, Betsy ^g   Naar King, Sylvie ^h   Nichols, Sharon ⁱ  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^d TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^e CHILDREN'S MEMORIAL HOSPITAL   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

^h WAYNE STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CAREGIVER; CHILD; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; JUVENILE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARENT; PERINATAL INFECTION; PILL; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECALL; SCHOOL CHILD; SELF REPORT; VALIDITY; VIROTHERAPY; VIRUS LOAD; BLOOD; LONGITUDINAL STUDY; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; QUESTIONNAIRE; REPRODUCIBILITY; STATISTICS;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; CAREGIVERS; CHILD; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PARENTS; PATIENT COMPLIANCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; VIRAL LOAD; YOUNG ADULT;

EID: 58149157496     PISSN: 0196206X     EISSN: None     Source Type: Journal    
DOI: 10.1097/DBP.0b013e3181856d22     Document Type: Article

References (28)

1. Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345: 1522-1528.
2. Miller LD, Hayes RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read. 2000;10:177-185.
3. World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access, recommendations for a public health approach. 2006. Available at: www.who.int/hiv/pub/guidelines. Accessed October 1, 2007.
4. Simoni JM, Montgomery A, Martin E, et al. Adherence to antiretroviral therapy for pediatric HIV infeciton: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119:e1371-e1383.
5. Naar-King S, Frey M, Harris M, Arfken C. Measuring adherence to treatment of paediatric HIV/AIDS. AIDS Care. 2005;17:345-349.
6. Steele RG, Anderson B, Rindel B, et al. Adherence to antiretroviral therapy among HIV-positive children: examination of the role of caregiver health beliefs. AIDS Care. 2001;13:617-629.
7. Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents. S Afr Med J. 2004;94:643-646.
8. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109:e61.
9. Williams PL, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006;118:e1745- e1757.
10. Pediatric AIDS Clinical Trials Group. PACTG Pediatric Adherence Questionnaire, Modules 1 & 2. Available at: www.fstrf.org/qol/ peds/pedadhere.html. Accessed October 1, 2007.
11. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments. AIDS Care. 2000;12:255-266.
12. Gortmaker SL, Lenderking WR, Clark C, et al. Development and use of a pediatric quality of life questionnaire in AIDS clinical trials: reliability and validity of the General Health Assessment for Children (GHAC). In: Drotar D, ed. Assessing Pediatric Health-Related Quality of Life and Functional Status: Implications for Research, Practice and Policy. Mahwah, New Jersey: Lawrence Feldbaum, Associates; 1998:219-235.
13. Storm DS, Boland MG, Gortmaker SL, et al. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection. Pediatrics. 2005;115:e173-e182.
14. Lee GM, Gortmaker SL, McIntosh K, Hughes MD, Oleske JM, for the Pediatric AIDS Clinical Trials Group Protocol 219C Team. Quality of life in HIV-infected children. Pediatrics. 2006;117:273-283.
15. Anderson BH, Auslander WF, Jung KC, Miller JP, Santiago JV. Assessing family sharing of diabetes responsibilities. J Pediatr Psychol. 1990;5:477-492.
16. Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(suppl 1):S79-S87.
17. Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr. 2003;33:211-218.
18. Johnson SB. Chronic disease of childhood: assessing compliance with complex medical regimens. In: Krasnegor MA, Epstein L, Johnson SB, Yaffe SJ, eds. Developmental Aspects of Health Compliance Behavior. Hillsdale, NJ: Erlbaum; 1993:15-184.
19. Wiener L, Riekert K, Ryder C, Wood LV. Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible. AIDS Patient Care STDS. 2004;18:527-538.
20. Marhefka SL, Tepper VJ, Farley J, et al. Brief report: assessing adherence to pediatric antiretroviral regimens using the 24-hour recall interview. J Pediatr Psychol. 2006;31:989-994.
21. Podsadecki TJ, Vrijens BC, Tousset EP. White coat compliance patterns make therapeutic drug monitoring (TDM) a potentially unreliable tool for assessing long-term drug exposure. Presented at: 13th Conference on Retroviruses and Opportunistic Infections; 2006; Denver, CO.
22. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19:1148-1153.
23. Gibb DM, Goodall RL, Giacomet V, et al. Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatr Infect Dis J. 2003;22:56 - 62.
24. Marhefka SL, Farley JJ, Rodriguez JR, et al. Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP). AIDS Care. 2004;16: 323-338.
25. Dolezal C, Mellins C, Brackis-Cott E, Abrams E. The reliability of reports of medical adherence from children with HIV and their adult caregivers. J Pediatr Psychol. 2003;28:355-361.
26. Mellins CA, Backis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23:1035-1041.
27. Martin S, Elliott-Desorbo DK, Wolters PL, et al. Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral. Pediatr Infect Dis J. 2007;26:61-67.
28. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38:445-448.